中心或外科医生手术量是否影响微创与开放胰十二指肠切除术的采用:一项系统综述与荟萃回归
该系统综述与荟萃分析比较微创与开放胰十二指肠切除术,纳入43项比较队列研究(8755例)和3项注册研究(43735例)。结果显示,微创与开放组在B/C级胰瘘和30天死亡率上无显著差异,微创组术后肺部并发症和手术部位感染率更低、住院时间更短、R0切除率更高。荟萃回归未发现中心手术量对B/C级胰瘘或30天死亡率有混杂影响。
要点
- 微创与开放胰十二指肠切除术的B/C级胰瘘和30天死亡率无显著差异。
- 微创组术后肺部并发症和手术部位感染率显著更低,住院时间更短,R0切除率更高。
- 微创胰十二指肠切除术可安全开展且结局良好,与年中心切除量无关。
核心结论
- 微创胰十二指肠切除术在B/C级术后胰瘘方面非劣于开放胰十二指肠切除术。
- 微创胰十二指肠切除术与显著更低的术后肺部并发症和手术部位感染率强相关。
- 微创胰十二指肠切除术可安全采用且结局良好,与年中心切除量无关。
研究设计与样本
- 纳入43项比较队列研究(8755例患者)和3项原始注册研究(43735例患者)。
主要发现
- 比较队列研究的中位年医院微创胰十二指肠切除术手术量为10。
- B/C级术后胰瘘的比值比为0.98(95%CI:0.78-1.23),微创与开放组无显著差异。
- 30天死亡率的比值比为1.14(95%CI:0.65-2.01),微创与开放组无显著差异。
- 微创胰十二指肠切除术与显著更低的术后肺部并发症和手术部位感染率、更短住院时间及显著更高的R0切缘切除率强相关。
临床怎么用
- 在评估开展微创胰十二指肠切除术时,中心年手术量不应作为限制采用的决定性因素。
- 微创胰十二指肠切除术可安全采用且结局良好,与年中心切除量无关。
局限性
- 比较队列研究的方法学质量中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There has been increasing uptake of minimally invasive pancreatoduodenectomy during the past decade, but it remains a highly specialized procedure as benefits over open pancreatoduodenectomy remain contentious. This study aimed to evaluate current evidence on minimally invasive pancreatoduodenectomy versus open pancreatoduodenectomy in terms of impact of center volume on outcomes. METHODS: A systematic review of articles on comparative cohort and registry studies on minimally invasive pancreatoduodenectomy versus open pancreatoduodenectomy published until 31st December 2019 were identified, and meta-analyses were performed. Primary endpoints were International Study Group on Pancreatic Fistula grade B/C postoperative pancreatic fistula and 30-day mortality. RESULTS: After screening 7,390 studies, 43 comparative cohort studies (8,755 patients) with moderate methodological quality and 3 original registry studies (43,735 patients) were included. For the cohort studies, the median annual hospital minimally invasive pancreatoduodenectomy volume was 10. No significant differences were found in grade B/C postoperative pancreatic fistula (odds ratio: 0.98, 95% confidence interval: 0.78-1.23) or 30-day mortality (odds ratio: 1.14, 95% confidence interval: 0.65-2.01) between minimally invasive pancreatoduodenectomy when compared with open. No publication biases were present and meta-regression identified no confounding for grade B/C postoperative pancreatic fistula, center volume or 30-day mortality. Minimally invasive pancreatoduodenectomy was only strongly associated with significantly lower rates of postoperative pulmonary complications and surgical site infection, shorter length of stay, and significantly higher rates of R0 margin resections. CONCLUSION: Minimally invasive pancreatoduodenectomy remains noninferior to open pancreatoduodenectomy for grade B/C postoperative pancreatic fistula but is strongly associated with significantly lower rates of postoperative pulmonary complications and surgical site infection. Minimally invasive pancreatoduodenectomy can be adopted safely with good outcomes irrespective of annual center resection volume.
引用
- Kamarajah SK, Abu Hilal M, White SA, et al. Does center or surgeon volume influence adoption of minimally invasive versus open pancreatoduodenectomy? A systematic review and meta-regression. Surgery. 2020. PMID: 33183790. doi:10.1016/j.surg.2020.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。